NCT03085914 2022-09-23A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)Incyte CorporationPhase 1/2 Completed70 enrolled 17 charts
NCT03347123 2022-02-28A Study of Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)Incyte CorporationPhase 1/2 Terminated11 enrolled 12 charts
NCT03277352 2021-07-22INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic MalignanciesIncyte CorporationPhase 1/2 Terminated10 enrolled 14 charts
NCT03361228 2020-05-21A Study to Evaluate the Safety, Tolerability, and Antitumor Activity of INCB001158 Plus Epacadostat, With or Without Pembrolizumab, in Advanced Solid TumorsIncyte CorporationPhase 1/2 Terminated5 enrolled 4 charts